Key result
Smart bioactive hydrogels integrating drug delivery, electroconductivity, and biosensing reduced infarct size by 20-45% and enhanced LVEF by 8-15% in preclinical models of myocardial infarction.
Why the study?
Conventional treatments often fail to effectively restore cardiac function after myocardial infarction, necessitating innovative biomaterials such as multifunctional smart bioactive hydrogels.
Do smart bioactive hydrogels improve regenerative outcomes in preclinical models of myocardial infarction compared to conventional scaffolds?
Population
Preclinical cardiac models in studies published between 2010 and 2025
Comparison
Multifunctional smart bioactive hydrogels vs conventional hydrogels without multifunctionality
Design
Narrative review
Authors
Loading...
Smart bioactive hydrogels may advance post-MI repair; leaves open clinical translation pending prospective trials.
Do smart bioactive hydrogels improve regenerative outcomes in preclinical models of myocardial infarction compared to conventional scaffolds?
Multifunctional smart bioactive hydrogels demonstrate superior regenerative outcomes compared to conventional scaffolds in preclinical models of myocardial infarction.
Nazir et al. (2025) conducted a review in Myocardial infarction. Smart bioactive hydrogels vs. Conventional scaffolds was evaluated. Smart bioactive hydrogels integrating drug delivery, electroconductivity, and biosensing reduced infarct size by 20-45% and enhanced LVEF by 8-15% in preclinical models of myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: